iLOF – From bold idea to €14M in funding
Success at a Glance About iLOF iLOF is a healthcare innovator from Portugal. It uses AI and photonics to transform drug development. The company’s technology enhances patient selection for clinical trials, focusing on diseases like Alzheimer’s, ovarian cancer, and COVID-19. EIT and Investor Support Key Milestones The Impact iLOF’s platform optimizes clinical trials with AI-driven …






